These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30489200)
21. Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops. Ng A; Keech A; Jones L Clin Ophthalmol; 2018; 12():695-700. PubMed ID: 29692601 [TBL] [Abstract][Full Text] [Related]
22. Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model. Niamprem P; Teapavarapruk P; Srinivas SP; Tiyaboonchai W Cornea; 2019 Apr; 38(4):485-491. PubMed ID: 30681516 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye. Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755 [TBL] [Abstract][Full Text] [Related]
24. The impact of artificial tears containing hydroxypropyl guar on mucous layer. Moon SW; Hwang JH; Chung SH; Nam KH Cornea; 2010 Dec; 29(12):1430-5. PubMed ID: 20805744 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial. Yeu E; Silverstein S; Guillon M; Schulze MM; Galarreta D; Srinivasan S; Manoj V Clin Ophthalmol; 2020; 14():2561-2570. PubMed ID: 32943837 [TBL] [Abstract][Full Text] [Related]
27. Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar. Uchiyama E; Di Pascuale MA; Butovich IA; McCulley JP Eye Contact Lens; 2008 Nov; 34(6):331-4. PubMed ID: 18997543 [TBL] [Abstract][Full Text] [Related]
28. Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells. Soriano-Romaní L; Vicario-de-la-Torre M; Crespo-Moral M; López-García A; Herrero-Vanrell R; Molina-Martínez IT; Diebold Y Exp Eye Res; 2017 Jan; 154():79-87. PubMed ID: 27840060 [TBL] [Abstract][Full Text] [Related]
29. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study. Bickle K; Miller JR; Tauber J; Awisi-Gyau D Ophthalmol Ther; 2024 Feb; 13(2):481-494. PubMed ID: 38079084 [TBL] [Abstract][Full Text] [Related]
30. Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. Tseng CL; Hung YJ; Chen ZY; Fang HW; Chen KH PLoS One; 2016; 11(6):e0157982. PubMed ID: 27336157 [TBL] [Abstract][Full Text] [Related]
31. [Toxicity of a new moistening agent and preservative in vitro]. Kasper K; Kremling C; Geerling G Ophthalmologe; 2008 Jun; 105(6):557-62. PubMed ID: 18214492 [TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives. López Bernal D; Ubels JL Curr Eye Res; 1991 Jul; 10(7):645-56. PubMed ID: 1914501 [TBL] [Abstract][Full Text] [Related]
33. Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation. Rangarajan R; Ketelson HA; Do R; McCanna DJ; Suko A; Enstone D; Subbaraman LN; Dantam J; Jones LW J Vis Exp; 2020 May; (159):. PubMed ID: 32420989 [TBL] [Abstract][Full Text] [Related]
34. Lubricant with gelling agent in treating dry eye in adult Chinese patients. Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726 [TBL] [Abstract][Full Text] [Related]
35. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Silverstein S; Yeu E; Tauber J; Guillon M; Jones L; Galarreta D; Srinivasan S; Manoj V Clin Ophthalmol; 2020; 14():3167-3177. PubMed ID: 33116367 [TBL] [Abstract][Full Text] [Related]
36. [In vitro evaluation of corneal damages after instillation of eye drops using rat debrided corneal epithelium: changes of corneal damage due to benzalkonium chloride by addition of thickening agents]. Nagai N; Ito Y; Okamoto N; Shimomura Y Yakugaku Zasshi; 2012; 132(7):837-43. PubMed ID: 22790030 [TBL] [Abstract][Full Text] [Related]
37. Corneal-protective effects of an artificial tear containing sodium hyaluronate and castor oil on a porcine short-term dry eye model. Hasegawa T; Amako H; Yamamoto T; Tazawa M; Sakamoto Y J Vet Med Sci; 2014 Sep; 76(9):1219-24. PubMed ID: 24881653 [TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride]. He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914 [TBL] [Abstract][Full Text] [Related]
39. Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers. Zhivov A; Kraak R; Bergter H; Kundt G; Beck R; Guthoff RF Curr Eye Res; 2010 Aug; 35(8):762-9. PubMed ID: 20673054 [TBL] [Abstract][Full Text] [Related]
40. Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye. Aguilar AJ; Marquez MI; Albera PA; Tredicce JL; Berra A Clin Ophthalmol; 2014; 8():2365-72. PubMed ID: 25473263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]